Literature DB >> 20620216

Repetitive domain of Clostridium difficile toxin B exhibits cytotoxic effects on human intestinal epithelial cells and decreases epithelial barrier function.

Mateja Zemljic1, Maja Rupnik, Melania Scarpa, Gregor Anderluh, Gorgio Palù, Ignazio Castagliuolo.   

Abstract

We have used recombinant repetitive domain of Clostridium difficile toxin B obtained from two different strains, rec-TcdB3(10463) and rec-TcdB3(8864) and a model intestinal epithelial cell line(s) to characterize their cytotoxic and cytopathic effect and influence on tight-junction organization. Both recombinant receptor binding domains caused intestinal epithelial cell damage, decreased transepithelial electrical resistance and induced translocation of ZO-1 from tight-junction proteins although less efficiently as holotoxins. Recombinant repetitive TcdB domains also caused stimulation of interleukin IL-8 synthesis in HT-29 cells. This is the first description of glucosyltransferase independent toxicity of TcdB and these C-terminal mediated effects may contribute to the pathophysiology of C. difficile infection.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620216     DOI: 10.1016/j.anaerobe.2010.06.010

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  8 in total

1.  A new role for heat shock factor 27 in the pathophysiology of Clostridium difficile toxin B.

Authors:  Murali K Yanda; William B Guggino; Liudmila Cebotaru
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-11       Impact factor: 4.052

Review 2.  Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.

Authors:  Yongrong Zhang; Hanping Feng
Journal:  Pathog Dis       Date:  2016-04-04       Impact factor: 3.166

3.  A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.

Authors:  Yuan-Kai Wang; Ya-Xian Yan; Hyeun Bum Kim; Xianghong Ju; Song Zhao; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2015-06-02       Impact factor: 3.452

Review 4.  Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview.

Authors:  Vidal Delgado-Rizo; Marco A Martínez-Guzmán; Liliana Iñiguez-Gutierrez; Alejandra García-Orozco; Anabell Alvarado-Navarro; Mary Fafutis-Morris
Journal:  Front Immunol       Date:  2017-02-06       Impact factor: 7.561

5.  Lacticaseibacillus casei Strain T21 Attenuates Clostridioides difficile Infection in a Murine Model Through Reduction of Inflammation and Gut Dysbiosis With Decreased Toxin Lethality and Enhanced Mucin Production.

Authors:  Wimonrat Panpetch; Pornpimol Phuengmaung; Thanya Cheibchalard; Naraporn Somboonna; Asada Leelahavanichkul; Somying Tumwasorn
Journal:  Front Microbiol       Date:  2021-12-01       Impact factor: 5.640

6.  A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.

Authors:  Robert G K Donald; Mike Flint; Narender Kalyan; Erik Johnson; Susan E Witko; Cheryl Kotash; Ping Zhao; Shakuntala Megati; Irina Yurgelonis; Phillip Kwok Lee; Yury V Matsuka; Elena Severina; Anne Deatly; Mini Sidhu; Kathrin U Jansen; Nigel P Minton; Annaliesa S Anderson
Journal:  Microbiology (Reading)       Date:  2013-04-29       Impact factor: 2.777

7.  The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.

Authors:  Ashleigh Hansen; Laurie Alston; Sarah E Tulk; L Patrick Schenck; Michael E Grassie; Basmah F Alhassan; Arun Teja Veermalla; Samir Al-Bashir; Fernand-Pierre Gendron; Christophe Altier; Justin A MacDonald; Paul L Beck; Simon A Hirota
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

8.  Soluble Non-Starch Polysaccharides From Plantain (Musa x paradisiaca L.) Diminish Epithelial Impact of Clostridioides difficile.

Authors:  Hannah L Simpson; Carol L Roberts; Louise M Thompson; Cameron R Leiper; Nehana Gittens; Ellie Trotter; Carrie A Duckworth; Stamatia Papoutsopoulou; Fabio Miyajima; Paul Roberts; Niamh O'Kennedy; Jonathan M Rhodes; Barry J Campbell
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.